Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.30 |
| ▸ | GABRP known ✓ | O00591 | 2/20 | 0.30 |
| ▸ | GABRD known ✓ | O14764 | 2/20 | 0.30 |
| ▸ | GABRA1 known ✓ | P14867 | 2/20 | 0.30 |
| ▸ | GABRB1 known ✓ | P18505 | 2/20 | 0.30 |
| ▸ | GABRG2 known ✓ | P18507 | 2/20 | 0.30 |
| ▸ | GABRB3 known ✓ | P28472 | 2/20 | 0.30 |
| ▸ | GABRA5 known ✓ | P31644 | 2/20 | 0.30 |
| ▸ | GABRA3 known ✓ | P34903 | 2/20 | 0.30 |
| ▸ | GABRA2 known ✓ | P47869 | 2/20 | 0.30 |
| ▸ | GABRB2 known ✓ | P47870 | 2/20 | 0.30 |
| ▸ | GABRA4 known ✓ | P48169 | 2/20 | 0.30 |
| ▸ | GABRE known ✓ | P78334 | 2/20 | 0.30 |
| ▸ | GABRA6 known ✓ | Q16445 | 2/20 | 0.30 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 2/20 | 0.30 |
| ▸ | GABRG3 known ✓ | Q99928 | 2/20 | 0.30 |
| ▸ | GABRQ known ✓ | Q9UN88 | 2/20 | 0.30 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TET2 | Q6N021 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL5376671 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TET2TET3TET1GRIK1 | |
| Trimethylammonium SCHEMBL8162324 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TET2TET3TET1GRIK1 | |
| Methacrylic Acid SCHEMBL5280757 | 0.94 | ALDH1A1 (0.36) | ALDH1A1TET2TET3TET1 | |
| Hydrochloric Acid SCHEMBL1961274 | 0.94 | ALDH1A1 (0.43) | ALDH1A1TET2TET3TET1GRIK1 | |
| SCHEMBL27792 | 0.92 | ALDH1A1 (0.45) | ALDH1A1TET2TET3TET1GRIK1 | |
| Hydrochloric Acid SCHEMBL8601576 | 0.87 | ALDH1A1 (0.36) | ALDH1A1TET2TET3TET1 | |
| Hydrochloric Acid SCHEMBL8601598 | 0.87 | ALDH1A1 (0.36) | ALDH1A1TET2TET3TET1 | |
| Methacrylic Acid SCHEMBL7773092 | 0.86 | ALDH1A1 (0.41) | ALDH1A1TET2TET3TET1GRIK1 | |
| SCHEMBL6654840 | 0.81 | ALDH1A1 (0.37) | ALDH1A1TET2TET3TET1GRIK1 | |
| SCHEMBL148011 | 0.79 | TET2 (0.40) | ALDH1A1TET2TET3TET1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 773 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2828317-B1 | HYDROPHILIC SILICONE MONOMERS, PROCESS FOR PREPARATION THEREOF AND THIN FILMS CONTAINING THE SAME | MOMENTIVE PERFORMANCE MAT INC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4713720-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| US-20260042269-A1 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | ALCON INC (CH) | 2026-02-12 | — | — | US | claimed |
| US-20260042268-A1 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | ALCON INC (CH) | 2026-02-12 | — | — | US | claimed |
| US-20250387989-A1 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | ALCON INC (CH) | 2025-12-25 | — | — | US | claimed |
| EP-4657144-A2 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | Alcon Inc. (CH) | 2025-12-03 | — | — | EP | claimed |
| EP-4657145-A2 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | Alcon Inc. (CH) | 2025-12-03 | — | — | EP | claimed |
| US-12420501-B2 | Silicone hydrogel lenses with water-rich surfaces | ALCON INC. (CH) | 2025-09-23 | — | — | US | claimed |
| WO-2024236526-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC. (CH) | 2024-11-21 | — | — | WO | claimed |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC (CH) | 2024-11-21 | — | — | US | claimed |
| JP-2004517360-A | — | — | 2004-06-10 | — | — | JP | claimed |
| EP-1402288-A1 | POLYMERIC MATERIALS FOR MAKING CONTACT LENSES | Novartis AG (CH) | 2004-03-31 | — | — | EP | claimed |
| EP-1360527-A2 | A TINTED, HIGH DK OPHTHALMIC MOLDING AND A METHOD FOR MAKING SAME | Novartis AG (CH) | 2003-11-12 | — | — | EP | claimed |
| US-20030008154-A1 | Acrylated polyethersiloxane copolymer containing isocyanate groups | ALCON INC. (CH) | 2003-01-09 | — | — | US | claimed |
| WO-2002097481-A1 | POLYMERIC MATERIALS FOR MAKING CONTACT LENSES | NOVARTIS AG (CH) | 2002-12-05 | — | — | WO | claimed |
| WO-2002054136-A2 | A TINTED, HIGH DK OPHTHALMIC MOLDING AND A METHOD FOR MAKING SAME | NOVARTIS AG (CH) | 2002-07-11 | — | — | WO | claimed |
| EP-0820601-B1 | POLYSILOXANE-COMPRISING PERFLUOROALKYL ETHERS, AND THE PREPARATION AND USE THEREOF | NOVARTIS AG (CH) | 1999-12-22 | — | — | EP | claimed |
| US-5945498-A | CONTACT LENSES; CORNEAL IMPLANTS | NOVARTIS AG (CH) | 1999-08-31 | — | — | US | claimed |
| EP-0820601-A1 | POLYSILOXANE-COMPRISING PERFLUOROALKYL ETHERS, AND THE PREPARATION AND USE THEREOF | Novartis AG (CH) | 1998-01-28 | — | — | EP | claimed |
| WO-1996031791-A1 | POLYSILOXANE-COMPRISING PERFLUOROALKYL ETHERS, AND THE PREPARATION AND USE THEREOF | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042269-A1 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | CRYZ, STRA6, PHOSPHO1 | GAA 3973/4885GABRP 2155/4885GABRD 3690/4885 |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | VCL, HBS1L, SAAL1 | GAA 4075/4885GABRP 138/4885GABRD 16/4885 |
| US-20260042268-A1 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | STRA6, CRYZ, SMCHD1 | GAA 3183/4885GABRP 1817/4885GABRD 2690/4885 |
| US-20250387989-A1 | SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES | PHOSPHO1, MYOC, ASS1 | GAA 4731/4885GABRP 2442/4885GABRD 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.